Stay updated with breaking news from Dry segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Protein Hydrolysates Market by Product Type (Milk, Meats, Marine, Plant, Egg, Yeast), Application (Infant, Sports, Clinical...
Refinery Vacuum Distillation Units Market Size 2023 With The Rising Need To Broaden Viewpoint 2030 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
New Delhi [India], April 18 (ANI/PRNewswire): INALSA has expanded its current range of vacuum cleaners with the launch of 3 new models of wet & dry vacuum cleaners
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sientra Announces Pricing of Public Offering of Common Stock Sientra, Inc.February 9, 2021 GMT SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the pricing of its previously announced underwritten public offering. The Company will sell 5,410,628 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to Sientra, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $36.5 million. The offering is expected to close on or about February 11, 2021, subject to customary closing conditions. In addition, the Company has granted the underwriters a 30-day option to purchase up to 811,594 additional shares at the public offering price, less underwriting discounts and commissions.
Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020. Ron Menezes, President and Chief Executive Officer of Sientra, stated, “As the only breast aesthetics company committed exclusively to the plastic surgery channel, Sientra is focused on becoming the leader in novel treatments that progress the art of plastic surgery. Throughout 2020, Sientra increased investment in our breast aesthetics business, expanding our salesforce and production capacity, and launching strategic marketing programs tailored to the plastic surgery community to effectively drive new patients to their practices. We believe the results of our disciplined focus and execution are validated by our performance in Q4 2020, nearly doubling the year-over-year growth reported in Q3 2020. Importantly, this performance has provided strong momentum as we head into 2021, with these revenue trends continuing into Q1 2021 to date. Our 2021 strategy emphasizes our continued marketing focus to increase awareness of the Sientra brand among both women and surgeons. This campaign is designed to gain market share in private practices and hospitals, as well as drive home our scientific advantage and value to plastic surgeons.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Sientra, Inc.February 4, 2021 GMT Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020.